• Home
  • Team
    • Executive Team
    • Scientific and Professional Services Team
  • Services
    • Preclinical Drug Development
    • Early-Stage Clinical Development
    • Late-Stage Clinical Development & Commercialization
    • Advanced Development & Manufacturing Technologies
    • Regulatory Strategy & Submissions
    • Quality & Compliance
  • Case Studies
  • News
  • Careers
  • Contact
  • Home
  • Team
    • Executive Team
    • Scientific and Professional Services Team
  • Services
    • Preclinical Drug Development
    • Early-Stage Clinical Development
    • Late-Stage Clinical Development & Commercialization
    • Advanced Development & Manufacturing Technologies
    • Regulatory Strategy & Submissions
    • Quality & Compliance
  • Case Studies
  • News
  • Careers
  • Contact

Meet Leo Adalbert, Strategic Commercialization Subject Matter Expert

December 8, 2020 No Comments

Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today we highlight Dr. Robert Dennehy, NGT’s Crystallization and Solid State Expert.

Read More »

Dr. Robert Dennehy is Appointed to Strategic Advisory Board at CatSci

November 12, 2020 No Comments

NGT BioPharma’s Dr. Robert Dennehy is appointed to Strategic Advisory Board at CatSci.

Read More »

Meet Robert Dennehy, Crystallization and Solid-State Subject Matter Expert

November 11, 2020 No Comments

Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today we highlight Dr. Robert Dennehy, NGT’s Crystallization and Solid State Expert.

Read More »

Meet Malcolm Berry, API Continuous Processing Subject Matter Expert

November 3, 2020 No Comments

Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today we highlight Malcolm Berry, NGT’s API Continuous Processing expert.

Read More »

Listen to NGT’s API Expert Malcolm Berry at the Pharma 4.0 eConference!

September 16, 2020 No Comments

Listen to NGT’s API Expert Malcolm Berry at the Pharma 4.0 eConference!

Read More »

Current State of the Market for Antimicrobial Resistant (AMR) Medicines

August 12, 2020 No Comments

While the world focuses on COVID-19, NGT’s Michael K. O’Brien and Philip Chu provide insight on the current state of the market for antimicrobial resistant (AMR) medicines. Read the article in Applied Clinical Trials Online.

Read More »
Page1 Page2 Page3 Page4
  •  

    860.333.9023 • [email protected] • careers •

     


  • Terms of Use
  • Privacy Policy
  • Copyright Policy
  • Contact
2021 © Copyright NGT BioPharma Consultants

https://ngtbiopharmaconsultants.com/wp-content/uploads/2019/11/NGT-BioPharma-Consultants-Video.mp4